Skip to main content
. 2012 Aug 22;65(10):509–512. doi: 10.1038/ja.2012.67

Figure 1.

Figure 1

Geldanamycin (GA) inhibited Herpes simplex virus type 2 (HSV-2) replication in Vero cells in a dose-dependent manner. HSV-2 infected Vero cells were incubated in the absence or presence of GA at final concentration in the 0–0.5 μM range (0, 0.0625, 0.125, 0.25, 0.5 μM). Viral-reduced plaque assay was determined on 72 h post infection. A full color version of this figure is available at The Journal of Antibiotics journal online.